The Food and Drug Administration (FDA) has stated that Vytorin as safe, although the statin Zocor is believed to has comparatively better functionality and at lesser cost. Just last year, FDA raised doubts due to the recently done trial outcomes on Vytorin that has made it query the largely acknowledged notion that lowering LDL cholesterol levels reduces the risk of heart attacks and strokes. Especially bothersome were the observation of greater number of Vytorin users from the studies facing fatalities due to such occurrences as compared to Zocor (statin drug) users. The FDA has revised its safety reassessment of cholesterol-lessening medications and reiterated its stance that elevated LDL levels is a heart risk factor hence reducing it is considered optimal for health. The beginning of last year, physicians were flooded with calls from apprehensive Vytorin users (a single tablet combo having Zocor plus non-statin Zetia). A seven hundred plus entrant study at large by Vytorin’s  [...]